Pericardial malignant mesothelioma: a latent complication of radiotherapy?

February 19, 2008 | Comments Off on Pericardial malignant mesothelioma: a latent complication of radiotherapy?

European Journal of Cardiothoracic Surgery. 2008 Feb 13 [Epub ahead of print] [Link] Small GR, Nicolson M, Buchan K, Broadhurst P. Department of Cardiology, University of Aberdeen, Aberdeen, Scotland AB25…

Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case–control study

February 19, 2008 | Comments Off on Mesothelin-related predictive and prognostic factors in malignant mesothelioma: A nested case–control study

Lung Cancer. 2008 Feb 15 [Epub ahead of print] [Link] Roe OD, Creaney J, Lundgren S, Larsson E, Sandeck H, Boffetta P, Nilsen TI, Robinson B, Kjaerheim K. Department of…

The Lombardy Mesothelioma Register, Regional Operating Centre (ROC) of National Mesothelioma Register: organizative aspects

February 16, 2008 | Comments Off on The Lombardy Mesothelioma Register, Regional Operating Centre (ROC) of National Mesothelioma Register: organizative aspects

Epidemiologia e Prevenzione. 2007 Sep-Oct;31(5):283-9. [Link] Mensi C, Termine L, Canti Z, Rivolta G, Riboldi L, Pesatori AC, Chiappino G. Dipartimento di medicina preventiva, ambientale e del lavoro, Fondazione IRCCS-Ospedale…

Phase-contrast microscopy studies of early Cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis

February 13, 2008 | Comments Off on Phase-contrast microscopy studies of early Cisplatin-induced morphological changes of malignant mesothelioma cells and the correspondence to induced apoptosis

Experimental Lung Research. 2008 Feb;34(2):49-67. [Link] Janson V, Behnam-Motlagh P, Henriksson R, Hörstedt P, Engström KG, Grankvist K. Department of Medical Biosciences, Clinical Chemistry, UmeÃ¥ University, UmeÃ¥, Sweden. Abstract Cisplatin…

Expression of mesothelin as a potential diagnostic marker in mesothelioma

February 11, 2008 | Comments Off on Expression of mesothelin as a potential diagnostic marker in mesothelioma

Nihon Kokyuki Gakkai Zasshi. 2008 Jan;46(1):3-9. [Link] Kuribayashi K, Fukuoka K, Nakajima T, Miyake M, Miyata S, Tamura K, Iida S, Yamada S, Murakami A, Hirano H, Nakano T. Division…

Intensity-Modulated Radiotherapy for Resected Mesothelioma: The Duke Experience

February 11, 2008 | Comments Off on Intensity-Modulated Radiotherapy for Resected Mesothelioma: The Duke Experience

The International Journal of Radiation Oncology * Biology * Physics. 2008 Feb 7 [Epub ahead of print] [Link] Miles EF, Larrier NA, Kelsey CR, Hubbs JL, Ma J, Yoo S,…

Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis

February 11, 2008 | Comments Off on Nicotinic acetylcholine receptors in cancer: multiple roles in proliferation and inhibition of apoptosis

Trends in Pharmacological Sciences. 2008 Mar;29(3):151-8. Epub 2008 Feb 11. [Link] Egleton RD, Brown KC, Dasgupta P. Department of Pharmacology, Physiology and Toxicology, Joan C. Edwards School of Medicine, 1…

Ensemble methods for classification of patients for personalized medicine with high-dimensional data

February 8, 2008 | Comments Off on Ensemble methods for classification of patients for personalized medicine with high-dimensional data

Artificial Intelligence in Medicine. 2007 Nov;41(3):197-207. Epub 2007 Aug 23. [Link] Moon H, Ahn H, Kodell RL, Baek S, Lin CJ, Chen JJ. Department of Mathematics and Statistics, California State…

PTEN expression is a strong predictor of survival in mesothelioma patients

February 7, 2008 | Comments Off on PTEN expression is a strong predictor of survival in mesothelioma patients

European Journal of Cardiothoracic Surgery. 2008 Mar;33(3):502-6. Epub 2008 Jan 8. [Link] Opitz I, Soltermann A, Abaecherli M, Hinterberger M, Probst-Hensch N, Stahel R, Moch H, Weder W. Division of…

Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice

February 2, 2008 | Comments Off on Cost-effectiveness of pemetrexed plus cisplatin: malignant pleural mesothelioma treatment in UK clinical practice

Value in Health. 2008 Jan-Feb;11(1):4-12. [Link] Cordony A, Le Reun C, Smala A, Symanowski JT, Watkins J. M-TAG Pty Ltd, A Unit of IMS Health, St Leonards, NSW, Australia. acordony@au.imshealth.com…

Categories